Alimera Sciences launches first product

September 15, 2004

Atlanta -Start-up ophthalmic pharmaceutical developer Alimera Sciences Inc. has launched its first product, a multi-dose, emollient-based artificial tear drop.

Atlanta-Start-up ophthalmic pharmaceutical developer Alimera Sciences Inc. has launched its first product, a multi-dose, emollient-based artificial tear drop.

Soothe Emollient Eye Drops includes an advanced lipid restorative called Restoryl, designed to re-establish the eye's lipid layer to reduce tear evaporation for up to 8 hours.

Alimera Sciences licensed Soothe in November 2003 from Ocular Research of Boston, a group of eye-care specialists who focus on dry-eye research.